Resultados da busca - Elisabeth Miot‐Noirault
- Mostrando 1 - 9 resultados de 9
-
1
-
2
Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing por Aurélien Voissière, E. Jouberton, Elise Maubert, Françoise Degoul, Caroline Peyrode, Jean‐Michel Chezal, Élisabeth Miot-Noirault
Publicado em 2017Artigo -
3
Association of colorectal cancer with pathogenic<i>Escherichia coli</i>: Focus on mechanisms using optical imaging por Julie Véziant, Johan Gagnière, E. Jouberton, Virginie Bonnin, Pierre Sauvanet, Denis Pezet, Nicolas Barnich, Elisabeth Miot‐Noirault, Mathilde Bonnet
Publicado em 2016Artigo -
4
Pomegranate Peel Extract Prevents Bone Loss in a Preclinical Model of Osteoporosis and Stimulates Osteoblastic Differentiation in Vitro por Mélanie Spilmont, Laurent Léotoing, Marie-Jeanne Davicco, Patrice Lebecque, Élisabeth Miot-Noirault, Paul Pilet, Laurent Rios, Yohann Wittrant, Véronique Coxam
Publicado em 2015Artigo -
5
Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance. por Mohamad Yakhni, Arnaud Briat, Abderrahim El Guerrab, Ludivine Furtado, Fabrice Kwiatkowski, Elisabeth Miot-Noirault, F. Cachin, Frédérique Penault‐Llorca, Nina Radosevic‐Robin
Publicado em 2019Artigo -
6
The Free Fatty Acid Receptor G Protein-coupled Receptor 40 (GPR40) Protects from Bone Loss through Inhibition of Osteoclast Differentiation* por Fabien Wauquier, Claire Philippe, Laurent Léotoing, Sylvie Mercier, Marie-Jeanne Davicco, Patrice Lebecque, Jérôme Guicheux, Paul Pilet, Elisabeth Miot-Noirault, Vincent Poitout, Thierry Alquier, Véronique Coxam, Yohann Wittrant
Publicado em 2013Artigo -
7
Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment por Claudine Kiéda, Bouchra El Hafny‐Rahbi, Guillaume Collet, Nathalie Lamerant‐Fayel, Catherine Grillon, Alan Guichard, Józef Dulak, Alicja Józkowicz, Jerzy Kotlinowski, Konstantina C. Fylaktakidou, Aurélien Vidal, Philippe Auzeloux, Élisabeth Miot-Noirault, Jean‐Claude Belœil, Jean‐Maríe Lehn, Claude Nicolau
Publicado em 2013Artigo -
8
<sup>123</sup>I-BZA2 as a Melanin-Targeted Radiotracer for the Identification of Melanoma Metastases: Results and Perspectives of a Multicenter Phase III Clinical Trial por F. Cachin, Elisabeth Miot-Noirault, Brigitte Gillet, V. Isnardi, B. Labeille, Pierre Payoux, Nicolás Meyer, Serge Cammilleri, C. Gaudy, Micheline Razzouk‐Cadet, J.‐P. Lacour, F. Granel‐Brocard, Christelle Tychyj, Fathalah Benbouzid, Jean Daniel Grange, Françoise Baulieu, A. Kelly, C. Merlin, Danielle Mestas, Françoise Gachon, Jean‐Michel Chezal, Françoise Degoul, M. D’Incan
Publicado em 2013Artigo -
9
Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3–dependent sensitization por Alexandra Jurczak, Lauriane Delay, Julie Barbier, Nils Simon, Emerson Krock, Katalin Sándor, Nilesh M. Agalave, Resti Rudjito, Gustaf Wigerblad, Katarzyna Rogóż, Arnaud Briat, Elisabeth Miot-Noirault, A Martínez-Martínez, Dieter Brömme, Caroline Grönwall, Vivianne Malmström, Lars Klareskog, Spiro Khoury, Thierry Ferreira, Bonnie Labrum, Emmanuel Deval, Juan Miguel Jiménez‐Andrade, Fabien Marchand, Camilla I. Svensson
Publicado em 2021Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Biology
Cancer research
Biochemistry
Chemistry
Internal medicine
Cell biology
Bone resorption
Cancer
Endocrinology
In vitro
Osteoclast
Pathology
Pharmacology
Receptor
Activator (genetics)
Biotechnology
Bone remodeling
Immunology
In vivo
Inflammation
Molecular biology
Osteoporosis
RANKL
Signal transduction
Agonist
Angiogenesis
Antioxidant
Apoptosis
Bone pain